Serum Selenium Levels Predict Breast Cancer Prognosis

Research done in southern Sweden shows that three blood biomarkers of selenium availability correlated inversely with mortality from breast cancer. The lower the three selenium biomarker levels, the higher the mortality [Demircan 2021].

Breast cancer awareness
Assessment of selenium status at the time of breast cancer diagnosis identifies patients at exceptionally high risk for a poor prognosis. They are breast cancer patients with low levels of selenium, selenoprotein P, and glutathione peroxidase in their blood.

The blood biomarkers are:

  • Total selenium
  • Selenoprotein P
  • Glutathione peroxidase 3

Breast cancer patients with blood concentrations of these three selenium biomarkers in the highest quintile had significantly better chances of survival compared with patients whose blood levels of these substances were in the lowest quintile [Demircan 2021].

Breast cancer patients with low selenium status according to these three biomarkers had the highest mortality risk with an overall survival probability of approximately 50% after 8 years. The difference in survival between the breast cancer patients in the lowest selenium quintile compared to breast cancer patients with at least one biomarker in the highest quintile was especially notable [Demircan 2021]. read more

Selenium Status and Covid-19 Patients

In cases of severe Covid-19 disease, patients have significantly lower concentrations of selenium and selenoprotein P and significantly higher levels of oxidative stress. That is to say, there is a more intense formation of harmful free radicals in patients with severe Covid-19 disease [Skesters 2022].

Corona virus
An adequate supply of selenium and zinc and vitamin D is essential for resistance to the corona viruses and to other viral infections. Here, Skesters er al show that Covid-19 patients have significantly lower levels of plasma selenium and selenoprotein P and significantly higher levels of oxidative stress.

Note: Oxidative stress is the bio-medical term for an imbalance between harmful free radical activity and protective antioxidant activity. Selenium is a key component of antioxidant selenoproteins such as the glutathione peroxidases and the thioredoxin reductases.

Role of Selenium and Selenoprotein P in Covid-19 Disease

Researchers have been investigating the role that selenium may play in reducing the severity and mortality of Covid-19 infections. Studies have shown a close relationship between low selenium status, Selenoprotein P deficiency, oxidative stress level, and Covid-19 disease incidence, severity, and prognosis [Skesters 2022]. read more

Plasma Selenoprotein P Levels and the Risk of Cardiovascular Disease

Research conclusion: “The 20% with lowest SELENOP concentrations in a N orth European population without history of cardiovascular disease have markedly increased risk of cardiovascular morbidity and mortality” [Schomburg 2019].

Heart attack
Selenoprotein-P deficiency predicts cardiovascular disease and death. Low selenium intakes result in sub-optimal bio-synthesis of selenoprotein P in the liver. Now, research shows that low selenoprotein P concentrations are associated with increased risk of cardiovascular disease and mortality.

This is the conclusion from the Malmö Preventive Project, a population-based prospective cohort study in southern Sweden, that examined the relationship between plasma selenoprotein P status and 1) risk of all-cause mortality, 2) risk of cardiovascular mortality, and 3) risk of a first cardiovascular event in 4366 study participants.

Note that this was a study done with study participants who had no history of cardiovascular disease. It was truly a study of the relationship between selenium status and the risk of heart disease. read more